Autoimmune Disease Diagnostic and Management

Emerging Treatments and Disease-Specific Interventions
Erscheinungsjahr 2026
ISBN: 978-981-957489-6
Verlag: Springer

Buch, Englisch, 330 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 680 g

This contributed volume offers a comprehensive exploration of the latest advancements in diagnosing and managing autoimmune diseases, with a focus on emerging treatments and disease-specific interventions. It brings together leading experts from around the world to provide a detailed roadmap for addressing these conditions using cutting-edge approaches.

The chapters cover diverse topics, including the pathogenesis and management of rheumatoid arthritis, multiple sclerosis, and type 1 diabetes. Readers will discover innovations in early diagnosis, targeted drug delivery systems, and the application of nanomaterials in treatment. The book also highlights the role of precision medicine and advanced diagnostic techniques in improving patient outcomes, supported by detailed illustrations and expert analyses.

This book is an invaluable resource for graduate and postgraduate students, researchers, and policymakers interested in the latest strategies for autoimmune disease management. Offering a global perspective and multidisciplinary insights, it is a must-read for medical professionals and academics alike.

Zielgruppe

Research

Autoren/Hrsg.

Ansari, Md. Meraj

Akhtar, Nadeem

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Immunologie

Inhaltsverzeichnis

1. Autoimmune diseases: An overview.- 2. Early diagnosis and management of autoimmune diseases.- 3. Pathogenesis and Management of Rheumatoid Arthritis.- 4.    Advances in the Diagnosis and Treatment of Rheumatoid Arthritis.- 5. Pathogenesis and Management of Multiple Sclerosis.- 6. Advancements in the Early Diagnosis and Treatment of Multiple Sclerosis.- 7. Emergence of Targeted Drug Delivery in the Management of Multiple Sclerosis.- 8. Pathogenesis and Management of Diabetes Type 1.- 9. Recent Trends in the early Diagnosis and Treatment of Type 1 Diabetes.- 10. Pathogenesis and Management of Psoriasis.- 11. Early Diagnosis and Treatment of Psoriasis.- 12. Recent Advancements in Topical Drug Delivery Systems in the Management of Psoriasis.- 13. Systemic Lupus Erythematosus Pathogenesis and Management.- 14. Systemic Lupus Erythematosus: Pathogenesis and Manifestation.- 15. Targeted Drug Delivery Systems in the Management of Systemic Lupus Erythematosus.- 16. Role and Application of Machine Learning Techniques in Early Diagnosis and Management of Autoimmune Diseases.

Über Autor(innen)

Dr. Md. Meraj Ansari is a Lecturer and Postdoctoral Researcher at Jeju National University, South Korea, specializing in inflammatory biology. His work focuses on developing novel phytochemicals and nanocarrier-based drug delivery systems to prevent and treat inflammatory diseases such as rheumatoid arthritis, osteoarthritis, and colon cancer.
He earned his Ph.D. in Toxicology from Jamia Hamdard University, India, and has previously worked at the National Institute of Pharmaceutical Education and Research and the Institute of Nano Science and Technology in Mohali, India. Dr. Ansari has received the Young Scientist Award from the Department of Health Research, Government of India.

Dr. Nadeem Akhtar is a research scientist at CBS Bio Platforms Inc., Canada, using biotechnology to create sustainable feed and food solutions. With a strong academic and research background, he has developed innovative approaches in agriculture, nanobiotechnology, bioactives, nutraceuticals, and alternative proteins. Previously, he was a Research Associate at the University of Guelph and a Postdoctoral Researcher at the University of Guelph and the University of Waterloo. Dr. Akhtar's work focuses on making nutrition more sustainable and improving feed and food ecosystems for the future.